Modalis Therapeutics Corporation
Develops genetic medicines using a proprietary epigenome editing technology.
4883 | T
Overview
Corporate Details
- ISIN(s):
- JP3922600006
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町三丁目１１番５号
- Website:
- https://modalistx.com/en/
- Sector:
- Manufacturing
Description
Modalis Therapeutics Corporation is a biotechnology company developing precision genetic medicines for serious disorders. The company's core technology is CRISPR-GNDM®, a proprietary epigenome editing platform. This technology regulates the expression of specific genes—selectively activating or suppressing them—without altering the underlying DNA sequence or causing double-strand breaks. CRISPR-GNDM® utilizes a compact epigenome editor designed for efficient delivery to target cells using adeno-associated virus (AAV) vectors. The company advances its programs through a hybrid model of in-house development and collaborative partnerships, with a pipeline focused on therapeutic areas such as muscular disorders, cardiomyopathy, and central nervous system (CNS) disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-28 08:01 |
有価証券報告書－第7期(2022/01/01－2022/12/31)
|
Japanese | 1.7 MB | ||
| 2022-11-18 08:02 |
確認書
|
Japanese | 8.9 KB | ||
| 2022-11-18 08:00 |
訂正四半期報告書－第7期第2四半期(令和4年4月1日－令和4年6月30日)
|
Japanese | 172.7 KB | ||
| 2022-11-14 07:00 |
確認書
|
Japanese | 8.9 KB | ||
| 2022-11-14 07:00 |
四半期報告書－第7期第3四半期(令和4年7月1日－令和4年9月30日)
|
Japanese | 181.3 KB | ||
| 2022-08-12 08:00 |
確認書
|
Japanese | 8.9 KB | ||
| 2022-08-12 08:00 |
四半期報告書－第7期第2四半期(令和4年4月1日－令和4年6月30日)
|
Japanese | 237.9 KB | ||
| 2022-05-13 08:00 |
四半期報告書－第7期第1四半期(令和4年1月1日－令和4年3月31日)
|
Japanese | 184.0 KB | ||
| 2022-03-29 08:00 |
内部統制報告書－第6期(令和3年1月1日－令和3年12月31日)
|
Japanese | 23.0 KB | ||
| 2022-03-29 08:00 |
有価証券報告書－第6期(令和3年1月1日－令和3年12月31日)
|
Japanese | 1.7 MB | ||
| 2022-03-29 08:00 |
確認書
|
Japanese | 8.8 KB | ||
| 2021-11-15 07:01 |
四半期報告書－第6期第3四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | 150.3 KB | ||
| 2021-08-13 08:00 |
四半期報告書－第6期第2四半期(令和3年4月1日－令和3年6月30日)
|
Japanese | 185.2 KB | ||
| 2021-05-14 08:01 |
四半期報告書－第6期第1四半期(令和3年1月1日－令和3年3月31日)
|
Japanese | 144.6 KB | ||
| 2021-03-31 08:03 |
内部統制報告書－第5期(令和2年1月1日－令和2年12月31日)
|
Japanese | 22.9 KB |
Automate Your Workflow. Get a real-time feed of all Modalis Therapeutics Corporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Modalis Therapeutics Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Modalis Therapeutics Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
